丁苯酞联合奥拉西坦治疗血管性认知障碍的效果(3)
[7]齐倩倩,刘志娟,吕佩源.血管性认知功能障碍危险因素的研究进展[J].疑难病杂志,2015,12(7):1305-1309.
[8]刘敏,孙宏侠.奥拉西坦联合丁苯酞软胶囊治疗血管性痴呆患者的临床疗效[J].中国药物经济学,2016,6(10):78-79.
[9]Tabit CE,Chung WB,Hamburg NM,et al.Endothelial dysfunction in diabetes mellitus:molecular mechanisms and clinical implications[J].Rev Endocr Metab Disord,2014,11(1):61-74.
[10]Endemann DH,Schiffrin EL.Endothelial dysfunction[J].Am Soc Nephrol,2015,15(8):1983-1992.
[11]Izzard AS,Rizzoni D,Agabiti-Rosei E,et al.Small artery structure and hypertension:adaptive changes and target organ damage[J].Hypertens,2011,23(2):247-250.
[12]王東枝.丁苯酞联合奥拉西坦治疗轻度血管性认知功能障碍的有效性和安全性[J].中国医药导报,2016,13(29):52-55.
[13]Zhang Y,Li W,Yan T,et al.Early detection of lesions of dorsal artery of foot in patients with type 2 diabetes mellitus by high-frequency ultrasonography[J].J Huazhong Univ Sci Technolog Med Sci,2011,29(3):387-390.
[14]邹伟辉,吴梅泉,黄国栋,等.通心络联合尼莫地平及奥拉西坦对血管性认知障碍的疗效观察[J].中国当代医药,2016,23(15):78-80.
(收稿日期:2016-12-28 本文编辑:方菊花) (姚洁文 宋柳全)
[8]刘敏,孙宏侠.奥拉西坦联合丁苯酞软胶囊治疗血管性痴呆患者的临床疗效[J].中国药物经济学,2016,6(10):78-79.
[9]Tabit CE,Chung WB,Hamburg NM,et al.Endothelial dysfunction in diabetes mellitus:molecular mechanisms and clinical implications[J].Rev Endocr Metab Disord,2014,11(1):61-74.
[10]Endemann DH,Schiffrin EL.Endothelial dysfunction[J].Am Soc Nephrol,2015,15(8):1983-1992.
[11]Izzard AS,Rizzoni D,Agabiti-Rosei E,et al.Small artery structure and hypertension:adaptive changes and target organ damage[J].Hypertens,2011,23(2):247-250.
[12]王東枝.丁苯酞联合奥拉西坦治疗轻度血管性认知功能障碍的有效性和安全性[J].中国医药导报,2016,13(29):52-55.
[13]Zhang Y,Li W,Yan T,et al.Early detection of lesions of dorsal artery of foot in patients with type 2 diabetes mellitus by high-frequency ultrasonography[J].J Huazhong Univ Sci Technolog Med Sci,2011,29(3):387-390.
[14]邹伟辉,吴梅泉,黄国栋,等.通心络联合尼莫地平及奥拉西坦对血管性认知障碍的疗效观察[J].中国当代医药,2016,23(15):78-80.
(收稿日期:2016-12-28 本文编辑:方菊花) (姚洁文 宋柳全)